April 3, 2025
Clinical and echocardiographic outcomes of the first 500 patients in the Align-AR trial for pure AR

Clinical and echocardiographic outcomes of the first 500 patients in the Align-AR trial for pure AR

Video by PCR via YouTube
Go to Source
Clinical and echocardiographic outcomes of the first 500 patients in the Align-AR trial for pure AR

Jonathan Curio interviews Raj Makkar about the results of the Align-AR trial which he presented during the ACC.25 in Chicago.
The ALIGN-AR trial found the Trilogy valve safe and effective for aortic regurgitation, with high survival, strong device success, and improved heart function. These promising results will lead to further research, including expansion to lower-risk patients.

More info about the ACC 2025 Late Breaking Clinical Trials covered by PCRonline: https://www.pcronline.com/News/Whats-new-on-PCRonline/2025/ACC/PCR-ACC-Scientific-Sessions

#TAVI #ACC25

Go to Source